Felix Müller, MD, is leading the research project on hallucinogenic and entactogenic drugs. He has years of experience in conducting studies on the effects of MDMA, LSD, psilocybin, and mescaline and has published several papers in this field. Currently, he is running an innovative phase-II-study investigating the potential of LSD to improve symptoms in major depression.
Background: Studied philosophy, logic, theory of science and medicine at Ludwig-Maximilians-University Munich and graduated in philosophy and medicine. After obtaining his doctoral degree from Technical University Munich he joined the Department of Psychiatry as a resident in 2013. Subsequently, he became study physician and senior physician.